Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 9 | 2020 | 280 | 3.610 |
Why?
|
| Pregnancy Complications, Infectious | 12 | 2023 | 419 | 3.160 |
Why?
|
| Streptococcus agalactiae | 8 | 2020 | 107 | 2.750 |
Why?
|
| Prenatal Care | 6 | 2023 | 325 | 2.700 |
Why?
|
| Obstetrics | 5 | 2022 | 221 | 2.510 |
Why?
|
| Gynecology | 4 | 2022 | 217 | 2.440 |
Why?
|
| Antibiotic Prophylaxis | 5 | 2020 | 181 | 1.990 |
Why?
|
| Pregnancy | 42 | 2023 | 7573 | 1.670 |
Why?
|
| Chorioamnionitis | 2 | 2021 | 41 | 1.620 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2021 | 47 | 1.610 |
Why?
|
| Version, Fetal | 2 | 2020 | 6 | 1.550 |
Why?
|
| Social Media | 2 | 2022 | 203 | 1.150 |
Why?
|
| Cesarean Section | 7 | 2023 | 367 | 1.050 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2020 | 124 | 0.950 |
Why?
|
| Labor Stage, Second | 1 | 2023 | 15 | 0.920 |
Why?
|
| Periodicals as Topic | 2 | 2019 | 338 | 0.880 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2020 | 28 | 0.870 |
Why?
|
| Neonatal Sepsis | 1 | 2022 | 28 | 0.850 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2022 | 31 | 0.840 |
Why?
|
| Endometritis | 1 | 2021 | 9 | 0.830 |
Why?
|
| Penicillins | 2 | 2020 | 143 | 0.820 |
Why?
|
| Breech Presentation | 2 | 2020 | 22 | 0.820 |
Why?
|
| Surgical Mesh | 1 | 2022 | 209 | 0.760 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2023 | 581 | 0.760 |
Why?
|
| Peripartum Period | 1 | 2020 | 35 | 0.740 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 590 | 0.710 |
Why?
|
| Vulvar Lichen Sclerosus | 1 | 2019 | 7 | 0.710 |
Why?
|
| Sexism | 1 | 2019 | 51 | 0.700 |
Why?
|
| Genitalia, Female | 1 | 2019 | 68 | 0.670 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 335 | 0.660 |
Why?
|
| Lacerations | 1 | 2019 | 33 | 0.660 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 128 | 0.660 |
Why?
|
| Liability, Legal | 1 | 2018 | 48 | 0.660 |
Why?
|
| Fetal Death | 1 | 2018 | 113 | 0.650 |
Why?
|
| Stillbirth | 1 | 2018 | 82 | 0.640 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2019 | 129 | 0.630 |
Why?
|
| Platelet Count | 1 | 2019 | 490 | 0.630 |
Why?
|
| Delivery, Obstetric | 3 | 2022 | 227 | 0.610 |
Why?
|
| Cervix Uteri | 2 | 2017 | 253 | 0.600 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 2992 | 0.600 |
Why?
|
| Patient Preference | 1 | 2019 | 218 | 0.600 |
Why?
|
| Female | 50 | 2023 | 141928 | 0.600 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2020 | 234 | 0.590 |
Why?
|
| Parturition | 1 | 2017 | 65 | 0.580 |
Why?
|
| Bias | 1 | 2017 | 205 | 0.550 |
Why?
|
| Obstetric Labor Complications | 3 | 2007 | 95 | 0.550 |
Why?
|
| Infant, Newborn | 13 | 2023 | 8223 | 0.540 |
Why?
|
| Carrier State | 1 | 2015 | 90 | 0.530 |
Why?
|
| Humans | 61 | 2023 | 261506 | 0.520 |
Why?
|
| Telemedicine | 2 | 2021 | 471 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.500 |
Why?
|
| Pandemics | 2 | 2022 | 1559 | 0.490 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 482 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.420 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.420 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2017 | 2594 | 0.400 |
Why?
|
| Physicians | 1 | 2019 | 882 | 0.390 |
Why?
|
| Internship and Residency | 1 | 2022 | 1375 | 0.380 |
Why?
|
| Cerclage, Cervical | 2 | 2007 | 12 | 0.370 |
Why?
|
| Pregnancy Complications | 4 | 2021 | 526 | 0.360 |
Why?
|
| Erythromycin | 2 | 2021 | 22 | 0.350 |
Why?
|
| Biomedical Research | 1 | 2017 | 806 | 0.350 |
Why?
|
| Sepsis | 1 | 2014 | 652 | 0.340 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.330 |
Why?
|
| Gestational Age | 3 | 2023 | 1069 | 0.310 |
Why?
|
| Anticoagulants | 2 | 2020 | 787 | 0.300 |
Why?
|
| Hospitals, Community | 2 | 2007 | 79 | 0.300 |
Why?
|
| Postpartum Period | 3 | 2023 | 259 | 0.300 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 310 | 0.300 |
Why?
|
| Uterus | 2 | 2007 | 678 | 0.290 |
Why?
|
| United States | 6 | 2022 | 15433 | 0.290 |
Why?
|
| Hospitals, University | 1 | 2007 | 209 | 0.280 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 2006 | 3 | 0.280 |
Why?
|
| Prothrombin Time | 1 | 2006 | 44 | 0.280 |
Why?
|
| Genetic Testing | 1 | 2014 | 1589 | 0.280 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 945 | 0.280 |
Why?
|
| Cerebral Palsy | 1 | 2007 | 63 | 0.270 |
Why?
|
| Fluconazole | 1 | 2006 | 103 | 0.270 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1997 | 99 | 0.260 |
Why?
|
| Warfarin | 1 | 2006 | 152 | 0.250 |
Why?
|
| Pregnancy Outcome | 5 | 2021 | 643 | 0.240 |
Why?
|
| Retrospective Studies | 14 | 2023 | 37905 | 0.240 |
Why?
|
| Fetal Viability | 1 | 2023 | 29 | 0.230 |
Why?
|
| Labor Stage, First | 1 | 2023 | 6 | 0.230 |
Why?
|
| Vagina | 3 | 2021 | 317 | 0.230 |
Why?
|
| Parity | 1 | 2023 | 139 | 0.220 |
Why?
|
| Postpartum Hemorrhage | 1 | 2022 | 81 | 0.210 |
Why?
|
| China | 1 | 2023 | 606 | 0.200 |
Why?
|
| Azithromycin | 1 | 2021 | 78 | 0.200 |
Why?
|
| Pregnancy, Multiple | 3 | 2014 | 45 | 0.200 |
Why?
|
| Surgical Instruments | 1 | 2021 | 138 | 0.200 |
Why?
|
| Urinary Retention | 1 | 2021 | 21 | 0.190 |
Why?
|
| Decision Making | 2 | 2020 | 1287 | 0.190 |
Why?
|
| Desogestrel | 1 | 2020 | 5 | 0.190 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 196 | 0.190 |
Why?
|
| Morbidity | 1 | 2021 | 397 | 0.190 |
Why?
|
| Simulation Training | 1 | 2022 | 149 | 0.180 |
Why?
|
| Contraceptive Agents, Female | 1 | 2020 | 38 | 0.180 |
Why?
|
| Adult | 17 | 2023 | 77950 | 0.180 |
Why?
|
| Contraception | 1 | 2020 | 49 | 0.180 |
Why?
|
| Antifungal Agents | 1 | 2006 | 834 | 0.180 |
Why?
|
| Uterine Contraction | 2 | 1997 | 31 | 0.180 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 330 | 0.180 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2019 | 45 | 0.180 |
Why?
|
| Birth Injuries | 1 | 1999 | 24 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 2403 | 0.170 |
Why?
|
| Abortion, Spontaneous | 1 | 2020 | 112 | 0.170 |
Why?
|
| Pain, Postoperative | 2 | 2021 | 610 | 0.170 |
Why?
|
| Hysterectomy | 1 | 2022 | 611 | 0.160 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 51 | 0.160 |
Why?
|
| Endometriosis | 1 | 2021 | 214 | 0.160 |
Why?
|
| Twins | 2 | 2014 | 70 | 0.160 |
Why?
|
| Maternal Age | 1 | 2018 | 152 | 0.160 |
Why?
|
| Abruptio Placentae | 1 | 1997 | 10 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2019 | 226 | 0.150 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2021 | 356 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 484 | 0.150 |
Why?
|
| Dystocia | 1 | 1997 | 22 | 0.150 |
Why?
|
| Probability | 1 | 2018 | 866 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 1099 | 0.150 |
Why?
|
| Betamethasone | 1 | 1996 | 16 | 0.150 |
Why?
|
| Anesthesia | 1 | 2020 | 296 | 0.140 |
Why?
|
| Rectus Abdominis | 1 | 1997 | 100 | 0.140 |
Why?
|
| Tocolytic Agents | 1 | 1996 | 7 | 0.140 |
Why?
|
| Terbutaline | 1 | 1996 | 27 | 0.140 |
Why?
|
| Vomiting | 1 | 2018 | 354 | 0.140 |
Why?
|
| Muscular Diseases | 1 | 1997 | 161 | 0.140 |
Why?
|
| Chlamydia trachomatis | 1 | 1995 | 30 | 0.140 |
Why?
|
| Diseases in Twins | 1 | 1996 | 99 | 0.140 |
Why?
|
| Nausea | 1 | 2018 | 525 | 0.140 |
Why?
|
| Hematoma | 1 | 1997 | 160 | 0.140 |
Why?
|
| Gastroplasty | 1 | 1995 | 22 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2020 | 548 | 0.140 |
Why?
|
| Coronary Aneurysm | 1 | 1996 | 36 | 0.140 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1996 | 37 | 0.140 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 51 | 0.130 |
Why?
|
| Obstetric Labor, Premature | 1 | 1996 | 80 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1996 | 100 | 0.130 |
Why?
|
| Heart Diseases | 2 | 2019 | 732 | 0.130 |
Why?
|
| Amoxicillin | 1 | 1995 | 106 | 0.130 |
Why?
|
| Term Birth | 1 | 2014 | 30 | 0.130 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1994 | 29 | 0.130 |
Why?
|
| Herpes Genitalis | 1 | 1994 | 17 | 0.130 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 481 | 0.120 |
Why?
|
| Heart Transplantation | 2 | 2012 | 908 | 0.120 |
Why?
|
| Thromboembolism | 1 | 1995 | 155 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 860 | 0.120 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1994 | 140 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 1085 | 0.120 |
Why?
|
| Odds Ratio | 2 | 2015 | 2316 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 915 | 0.120 |
Why?
|
| Postoperative Complications | 2 | 2022 | 5542 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 1335 | 0.120 |
Why?
|
| Aneuploidy | 1 | 2014 | 369 | 0.110 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1995 | 340 | 0.110 |
Why?
|
| Fibrinolytic Agents | 1 | 1995 | 324 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 1996 | 629 | 0.110 |
Why?
|
| Heart Failure, Systolic | 1 | 2012 | 32 | 0.110 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 121 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6100 | 0.100 |
Why?
|
| Heart-Assist Devices | 2 | 2012 | 1171 | 0.100 |
Why?
|
| Heart Atria | 1 | 1994 | 352 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2021 | 12873 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 694 | 0.100 |
Why?
|
| Dilatation | 2 | 2023 | 83 | 0.100 |
Why?
|
| Catheterization, Central Venous | 1 | 1994 | 354 | 0.100 |
Why?
|
| Age Factors | 2 | 2019 | 5377 | 0.100 |
Why?
|
| Risk Factors | 4 | 2021 | 17523 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2022 | 32848 | 0.100 |
Why?
|
| Middle Aged | 5 | 2021 | 86204 | 0.100 |
Why?
|
| Recurrence | 2 | 2015 | 4758 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 244 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2009 | 306 | 0.080 |
Why?
|
| Myocarditis | 1 | 2011 | 190 | 0.080 |
Why?
|
| Colony Count, Microbial | 1 | 2008 | 149 | 0.080 |
Why?
|
| Thrombosis | 1 | 1994 | 781 | 0.080 |
Why?
|
| Cervical Length Measurement | 1 | 2007 | 16 | 0.080 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2007 | 8 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 5687 | 0.070 |
Why?
|
| Mass Screening | 1 | 2015 | 1509 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 1996 | 1374 | 0.070 |
Why?
|
| Elective Surgical Procedures | 1 | 2007 | 250 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 622 | 0.060 |
Why?
|
| Young Adult | 2 | 2020 | 21445 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2007 | 4744 | 0.060 |
Why?
|
| Adolescent | 3 | 2019 | 31252 | 0.050 |
Why?
|
| Michigan | 1 | 2021 | 67 | 0.050 |
Why?
|
| Texas | 2 | 2007 | 6311 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 245 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2021 | 48 | 0.050 |
Why?
|
| Logistic Models | 2 | 2020 | 3441 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2021 | 210 | 0.050 |
Why?
|
| Curettage | 1 | 2020 | 22 | 0.050 |
Why?
|
| Drug Implants | 1 | 2020 | 46 | 0.050 |
Why?
|
| Prevalence | 1 | 2008 | 3260 | 0.050 |
Why?
|
| Puerperal Disorders | 1 | 2020 | 41 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 97 | 0.050 |
Why?
|
| Postnatal Care | 1 | 2020 | 47 | 0.050 |
Why?
|
| Birth Weight | 1 | 2021 | 374 | 0.040 |
Why?
|
| Male | 5 | 2019 | 123000 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 1697 | 0.040 |
Why?
|
| Patient Selection | 1 | 2007 | 2055 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 464 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1997 | 36 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 70117 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2021 | 953 | 0.040 |
Why?
|
| Trial of Labor | 1 | 1997 | 27 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2021 | 830 | 0.040 |
Why?
|
| Incidence | 2 | 1997 | 5673 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2023 | 1863 | 0.030 |
Why?
|
| Contraindications | 1 | 1996 | 150 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1997 | 756 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 90 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 500 | 0.030 |
Why?
|
| Cesarean Section, Repeat | 1 | 1994 | 10 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 2203 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1995 | 251 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 1995 | 224 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2218 | 0.030 |
Why?
|
| History, 20th Century | 1 | 1995 | 574 | 0.030 |
Why?
|
| Time Factors | 1 | 2006 | 12926 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 1371 | 0.020 |
Why?
|
| Infant, Premature | 1 | 1996 | 787 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2011 | 42 | 0.020 |
Why?
|
| Reoperation | 1 | 1995 | 1382 | 0.020 |
Why?
|
| Hemorrhage | 1 | 1995 | 712 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 380 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 467 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 263 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2023 | 9244 | 0.020 |
Why?
|
| North America | 1 | 2011 | 314 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2012 | 749 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2011 | 228 | 0.020 |
Why?
|
| Obesity | 1 | 2021 | 2884 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1995 | 3719 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2292 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2012 | 16273 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 610 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 4971 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6009 | 0.010 |
Why?
|
| Premature Birth | 1 | 2007 | 407 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6207 | 0.010 |
Why?
|
| Child | 2 | 2012 | 29154 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
| Infant | 1 | 2011 | 13310 | 0.010 |
Why?
|